Repurposed drug may be first targeted treatment for serious kidney disease
Friday, November 8, 2013 - 16:00
in Health & Medicine
A team of researchers is reporting that treatment with abatacept appeared to halt the course of focal segmental glomerulosclerosis in five patients, preventing four from losing transplanted kidneys and achieving disease remission in the fifth.